Related Experiment Videos
One-stage endometrial ablation: results in 200 cases
1Department of Surgery, Elisabeth Hospital, Sijsele, Belgium.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|February 28, 1992
Summary
Simplified endometrial ablation (EA) by omitting hormonal pretreatment and performing it during menstruation significantly improves treatment efficiency. This single-stage procedure offers a safe and effective option for dysfunctional uterine bleeding.
Area of Science:
- Gynecology
- Minimally Invasive Surgery
Background:
- Traditional endometrial ablation (EA) involves multiple steps, including hysteroscopic sampling and hormonal pretreatment with Danazol.
- These steps add complexity and potential side effects to the procedure for treating dysfunctional uterine bleeding.
Purpose of the Study:
- To evaluate the efficacy and safety of a simplified, single-stage endometrial ablation (EA) procedure.
- To determine if omitting hormonal pretreatment and performing EA during menstruation improves outcomes.
Main Methods:
- A single-stage endometrial ablation (EA) procedure was performed between days 2-7 of the menstrual cycle, omitting hormonal pretreatment.
- The procedure combined endometrial sampling (D&C or hysteroscopy) and ablation in one stage.
- Two main methods of endometrial destruction, electrocoagulation and Nd/Yag laser, were utilized.
Main Results:
- The simplified EA procedure demonstrated high efficacy, with 97.5% of patients achieving good results.
- Outcomes included 67% complete amenorrhea, 24% slight spotting, and 6% reduced menstrual flow.
- The procedure was safe, with only 2.5% experiencing mild complications. Dysmenorrhea was resolved in 73% of cases.
Conclusions:
- Omitting hormonal pretreatment and performing endometrial ablation (EA) during the early follicular phase (days 2-7 of menses) simplifies the procedure.
- This single-stage EA is a feasible, efficient, and safe treatment for dysfunctional uterine bleeding and associated dysmenorrhea.
- Further research is needed to confirm if combining electrocoagulation and Nd/Yag laser offers advantages over single-modality ablation.